Multiple Endocrine Neoplasia Type 1: Latest Insights

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology
• Oncology

Background:

• Multiple endocrine neoplasia type 1 (MEN1) is an inherited tumor syndrome with significant clinical interest across multiple specialties.
• Existing clinical practice guidelines for MEN1 are outdated, necessitating an updated review of recent scientific advancements.

Purpose of the Study:

• To provide a comprehensive review of the latest research on the basic biology, clinical features, and management of MEN1.
• To discuss recent insights into the pathogenesis, genetic diagnosis, and therapeutic strategies for MEN1-associated tumors.

Main Methods:

• Review of recent literature on MEN1, including basic science, clinical studies, and preclinical models.
• Analysis of advancements in genetic diagnosis, understanding of molecular interactions, and clinical presentation in specific populations (children, pregnancy).

Main Results:

• New insights into menin protein interactions and cell signaling pathways (TGF-β/BMP, nuclear receptors, Wnt/β-catenin, Hedgehog) have clarified MEN1 pathogenesis.
• Advancements in genetic diagnosis aid in identifying MEN1 in mutation-negative individuals.
• Growing knowledge on clinical presentation in pediatric and pregnant patients informs management strategies.

Conclusions:

• Recent discoveries in MEN1 biology and clinical features necessitate updated clinical practice guidance.
• Emerging understanding of sporadic neuroendocrine tumors and quality of life studies pave the way for targeted therapies and improved patient care.